Skip to content

Clinical trials

Lung Diseases trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: New Zealand Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20162
20191
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AIRNA Corporation1
Checkpoint Therapeutics, Inc.1
Intellia Therapeutics1
Pharmosa Biopharm Inc.1
Pulmovant, Inc.1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases8
Respiratory Tract Diseases4
Hypertension, Pulmonary2
Pulmonary Disease, Chronic Obstructive2
alpha 1-Antitrypsin Deficiency2
Adenocarcinoma1
Bronchial Diseases1
COVID-191
Carcinoma, Non-Small-Cell Lung1
Cardiovascular Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.